Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
American Journal of Obstetrics and Gynecology|April 22, 2006
Circulating cell-free fetal messenger RNA levels after fetoscopic interventions of complicated pregnanciesMay Lee Tjoa, Jacques Jani, Liesbeth Lewi, et al.
American Journal of Perinatology|March 20, 2026
Plain Language Summary of Publication: Design of the Global Prospective Hemolytic Disease of the Fetus and Newborn Registry (GERANIUM)May Lee Tjoa, Ashley Orillion, Raymond Mankoski, et al.
American Journal of Perinatology|March 20, 2026
Study Design of the Global Prospective Hemolytic Disease of the Fetus and Newborn Registry (GERANIUM)May Lee Tjoa, Ashley Orillion, Raymond Mankoski, et al.
Prenatal Diagnosis|February 8, 2003
Circulating trophoblast in maternal bloodCees B M Oudejans, May Lee Tjoa, Bart A Westerman, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 23, 2003
Plasma hepatocyte growth factor as a marker for small-for-gestational age fetusesMay Lee Tjoa, Monique A M Mulders, John M G van Vugt, et al.
Clinical Chemistry and Laboratory Medicine|July 21, 2004
Neurokinin B levels in maternal circulation during early pregnancyMay Lee Tjoa, Marie Lomecky, Frans Martens, et al.
American Journal of Perinatology|December 30, 2025
The Ethics of Clinical Research on Diseases of the Fetus and Newborn: Balancing Benefit-Risk, Autonomy, and Maternal-Fetal InterestsRobert M Nelson, Karla Childers, Leona E Ling, et al.
AJOG Global Reports|August 12, 2025
Clinical characteristics and outcomes of pregnancies at-risk of hemolytic disease of the fetus and newborn in Sweden, Finland, and Denmark: a population-based register studyKelvin H M Kwok, Mika Gissler, Mette Ø Thunbo, et al.
American Journal of Perinatology|August 28, 2024
Design of a Phase 3, Global, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and NewbornYosuke Komatsu, E J T Joanne Verweij, Eleonor Tiblad, et al.
NEJM Evidence|January 27, 2026
Infant Immunity after Maternal Nipocalimab in Severe Hemolytic Disease of the Fetus and NewbornDerek P de Winter, Kenneth J Moise, Leona E Ling, et al.
Pageof 3